{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T21:52:55Z","timestamp":1655502775453},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,27]],"date-time":"2013-01-27T00:00:00Z","timestamp":1359244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00115-012-3638-y","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T14:25:06Z","timestamp":1359123906000},"page":"143-150","source":"Crossref","is-referenced-by-count":3,"title":["Genetik von Bewegungsst\u00f6rungen"],"prefix":"10.1007","volume":"84","author":[{"given":"K.","family":"Lohmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,27]]},"reference":[{"key":"3638_CR1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM et al (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"3638_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","volume":"52","author":"Lee","year":"2006","unstructured":"Lee VM, Trojanowski JQ (2006) Mechanisms of Parkinson\u2019s disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52:33\u201338","journal-title":"Neuron"},{"key":"3638_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/WCO.0b013e3283547627","volume":"25","author":"Kumar","year":"2012","unstructured":"Kumar KR, Lohmann K, Klein C (2012) Genetics of Parkinson disease and other movement disorders. Curr Opin Neurol 25:466\u2013474","journal-title":"Curr Opin Neurol"},{"key":"3638_CR4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"3638_CR5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318\u20131320","journal-title":"Nat Med"},{"key":"3638_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607","journal-title":"Neuron"},{"key":"3638_CR7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590","journal-title":"Lancet Neurol"},{"key":"3638_CR8","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/molbev\/msl114","volume":"23","author":"Marin","year":"2006","unstructured":"Marin I (2006) The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol Biol Evol 23:2423\u20132433","journal-title":"Mol Biol Evol"},{"key":"3638_CR9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(05)74809-1","volume":"365","author":"Toft","year":"2005","unstructured":"Toft M, Mata IF, Kachergus JM et al (2005) LRRK2 mutations and Parkinsonism. Lancet 365:1229\u20131230","journal-title":"Lancet"},{"key":"3638_CR10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.25136","volume":"27","author":"Tofaris","year":"2012","unstructured":"Tofaris GK (2012) Lysosome-dependent pathways as a unifying theme in Parkinson\u201as disease. Mov Disord 27:1364\u20131369","journal-title":"Mov Disord"},{"key":"3638_CR11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"Lucking","year":"2000","unstructured":"Lucking CB, Durr A, Bonifati V et al (2000) Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene. N Engl J Med 342:1560\u20131567","journal-title":"N Engl J Med"},{"key":"3638_CR12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","volume":"6","author":"Klein","year":"2007","unstructured":"Klein C, Lohmann-Hedrich K, Rogaeva E et al (2007) Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6:652\u2013662","journal-title":"Lancet Neurol"},{"key":"3638_CR13","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s00018-012-0978-5","volume":"69","author":"Walden","year":"2012","unstructured":"Walden H, Martinez-Torres RJ (2012) Regulation of Parkin E3 ubiquitin ligase activity. Cell Mol Life Sci 69:3053\u20133067","journal-title":"Cell Mol Life Sci"},{"key":"3638_CR14","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","volume":"101","author":"Lo","year":"2004","unstructured":"Lo Bianco C, Schneider BL, Bauer M et al (2004) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 101:17510\u201317515","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3638_CR15","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/01.WNL.0000163999.72864.FD","volume":"64","author":"Albanese","year":"2005","unstructured":"Albanese A, Valente EM, Romito LM et al (2005) The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology 64:1958\u20131960","journal-title":"Neurology"},{"key":"3638_CR16","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1093\/hmg\/ddq215","volume":"19","author":"Rakovic","year":"2010","unstructured":"Rakovic A, Grunewald A, Seibler P et al (2010) Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients. Hum Mol Genet 19:3124\u20133137","journal-title":"Hum Mol Genet"},{"key":"3638_CR17","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312","journal-title":"Nat Genet"},{"key":"3638_CR18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661","journal-title":"N Engl J Med"},{"key":"3638_CR19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","volume":"77","author":"Brockmann","year":"2011","unstructured":"Brockmann K, Srulijes K, Hauser AK et al (2011) GBA-associated PD presents with nonmotor characteristics. Neurology 77:276\u2013280","journal-title":"Neurology"},{"key":"3638_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1212\/WNL.0b013e31825dd369","volume":"79","author":"Brockmann","year":"2012","unstructured":"Brockmann K, Hilker R, Pilatus U et al (2012) GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure. Neurology 79:213\u2013220","journal-title":"Neurology"},{"key":"3638_CR21","doi-asserted-by":"crossref","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"Lill","year":"2012","unstructured":"Lill CM, Roehr JT, McQueen MB et al (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease: the PDGene. PLoS Genet 8:e1002548","journal-title":"PLoS Genet"},{"key":"3638_CR22","unstructured":"Nalls M, Duran R, Lopez G et al (in press) A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. Arch Neurol"},{"key":"3638_CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.410410222","volume":"41","author":"Conrad","year":"1997","unstructured":"Conrad C, Andreadis A, Trojanowski JQ et al (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41:277\u2013281","journal-title":"Ann Neurol"},{"key":"3638_CR24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C et al (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610\u2013614","journal-title":"Ann Neurol"},{"key":"3638_CR25","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.54.9.1746","volume":"54","author":"Bressman","year":"2000","unstructured":"Bressman SB, Sabatti C, Raymond D et al (2000) The DYT1 phenotype and guidelines for diagnostic testing. Neurology 54:1746\u20131752","journal-title":"Neurology"},{"key":"3638_CR26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0031-1299783","volume":"31","author":"Fuchs","year":"2011","unstructured":"Fuchs T, Ozelius LJ (2011) Genetics of dystonia. Semin Neurol 31:441\u2013448","journal-title":"Semin Neurol"},{"key":"3638_CR27","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1242\/jcs.029454","volume":"121","author":"Nery","year":"2008","unstructured":"Nery FC, Zeng J, Niland BP et al (2008) TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J Cell Sci 121:3476\u20133486","journal-title":"J Cell Sci"},{"key":"3638_CR28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1474-4422(09)70081-X","volume":"8","author":"Bressman","year":"2009","unstructured":"Bressman SB, Raymond D, Fuchs T et al (2009) Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 8:441\u2013446","journal-title":"Lancet Neurol"},{"key":"3638_CR29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.22157","volume":"68","author":"Kaiser","year":"2010","unstructured":"Kaiser FJ, Osmanoric A, Rakovic A et al (2010) The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6). Ann Neurol 68:554\u2013559","journal-title":"Ann Neurol"},{"key":"3638_CR30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1194-236","volume":"8","author":"Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Takahashi E et al (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8:236\u2013242","journal-title":"Nat Genet"},{"key":"3638_CR31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1474-4422(12)70182-5","volume":"11","author":"Rosewich","year":"2012","unstructured":"Rosewich H, Thiele H, Ohlenbusch A et al (2012) Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol 11:764\u2013773","journal-title":"Lancet Neurol"},{"key":"3638_CR32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/344531","volume":"71","author":"M\u00fcller","year":"2002","unstructured":"M\u00fcller B, Hedrich K, Kock N et al (2002) Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71:1303\u20131311","journal-title":"Am J Hum Genet"},{"key":"3638_CR33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.celrep.2011.11.001","volume":"1","author":"Lee","year":"2012","unstructured":"Lee HY, Huang Y, Bruneau N et al (2012) Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 1:2\u201312","journal-title":"Cell Rep"},{"key":"3638_CR34","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1172\/JCI34438","volume":"118","author":"Weber","year":"2008","unstructured":"Weber YG, Storch A, Wuttke TV et al (2008) GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 118:2157\u20132168","journal-title":"J Clin Invest"},{"key":"3638_CR35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archneurol.2012.104","volume":"69","author":"Bruggemann","year":"2012","unstructured":"Bruggemann N, Spiegler J, Hellenbroich Y et al (2012) Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency. Arch Neurol 69:1071\u20131075","journal-title":"Arch Neurol"},{"key":"3638_CR36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.0b013e31824d58ab","volume":"78","author":"Marras","year":"2012","unstructured":"Marras C, Lohmann K, Lang A, Klein C (2012) Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology 78:1016\u20131024","journal-title":"Neurology"},{"key":"3638_CR37","doi-asserted-by":"crossref","first-page":"e1002171","DOI":"10.1371\/journal.pgen.1002171","volume":"7","author":"Winkelmann","year":"2011","unstructured":"Winkelmann J, Czamara D, Schormair B et al (2011) Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 7:e1002171","journal-title":"PLoS Genet"},{"key":"3638_CR38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2012.02.030","volume":"317","author":"Jimenez-Jimenez","year":"2012","unstructured":"Jimenez-Jimenez FJ, Garcia-Martin E, Lorenzo-Betancor O et al (2012) LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. J Neurol Sci 317:52\u201357","journal-title":"J Neurol Sci"},{"key":"3638_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1212\/WNL.0b013e31825fdeed","volume":"79","author":"Thier","year":"2012","unstructured":"Thier S, Lorenz D, Nothnagel M et al (2012) Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology 79:243\u2013248","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3638-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-012-3638-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3638-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T06:05:26Z","timestamp":1595311526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-012-3638-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,27]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["3638"],"URL":"https:\/\/doi.org\/10.1007\/s00115-012-3638-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,27]]}}}